These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24383848)

  • 21. Clinical challenges in a patient with dabigatran-induced fatal hemorrhage.
    Cano EL; Miyares MA
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):160-3. PubMed ID: 22386824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R; Salhanick SD; Chase M; Ganetsky M
    Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dabigatran: how the drug company withheld important analyses.
    Cohen D
    BMJ; 2014 Jul; 349():g4670. PubMed ID: 25055829
    [No Abstract]   [Full Text] [Related]  

  • 24. [New anticoagulants, new emergencies?].
    Djalali S
    Praxis (Bern 1994); 2013 Jul; 102(15):945-6. PubMed ID: 23876694
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
    Spannagl M; Bauersachs R; Debus ES; Gawaz M; Gerlach H; Haas S; Hach-Wunderle V; Lindhoff-Last E; Riess H; Schellong S; Schinzel H; Bode C
    Hamostaseologie; 2012; 32(4):294-305. PubMed ID: 23114798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The trouble with dabigatran.
    Charlton B; Redberg R
    BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830
    [No Abstract]   [Full Text] [Related]  

  • 27. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
    Won SY; Schlunk F; Dinkel J; Karatas H; Leung W; Hayakawa K; Lauer A; Steinmetz H; Lo EH; Foerch C; Gupta R
    Stroke; 2013 Oct; 44(10):2883-90. PubMed ID: 23920016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concerns over data in key dabigatran trial.
    Cohen D
    BMJ; 2014 Jul; 349():g4747. PubMed ID: 25055831
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatality in a patient treated with dabigatran.
    Schattner A; Kozak N; Friedman J
    Am J Emerg Med; 2013 Feb; 31(2):443.e1-2. PubMed ID: 22867831
    [No Abstract]   [Full Text] [Related]  

  • 31. What is the role of renal replacement therapy in the setting of dabigatran toxicity?
    Ghannoum M; Nolin TD
    Semin Dial; 2014; 27(3):223-6. PubMed ID: 24620942
    [No Abstract]   [Full Text] [Related]  

  • 32. Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
    Na SY; Mracsko E; van Ryn J; Veltkamp R
    Ann Neurol; 2015 Jul; 78(1):137-41. PubMed ID: 25899749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal bleeding associated with dabigatran.
    Schaeffer S; Conway SE
    Am J Health Syst Pharm; 2013 Oct; 70(19):1651-2. PubMed ID: 24048598
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Bouchard J; Ghannoum M; Bernier-Jean A; Williamson D; Kershaw G; Weatherburn C; Eris JM; Tran H; Patel JP; Roberts DM
    Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.
    Dumkow LE; Voss JR; Peters M; Jennings DL
    Am J Health Syst Pharm; 2012 Oct; 69(19):1646-50. PubMed ID: 22997117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Finsterer J; Stöllberger C; Paul G; Bastovansky A
    Cardiovasc Ther; 2013 Dec; 31(6):e111-4. PubMed ID: 24279385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
    Ross B; Miller MA; Ditch K; Tran M
    J Med Toxicol; 2014 Jun; 10(2):223-8. PubMed ID: 24385325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    Sipahi I; Celik S; Tozun N
    JAMA Intern Med; 2014 Jan; 174(1):150-1. PubMed ID: 24247291
    [No Abstract]   [Full Text] [Related]  

  • 39. Ischemic stroke in an obese patient receiving dabigatran.
    Breuer L; Ringwald J; Schwab S; Köhrmann M
    N Engl J Med; 2013 Jun; 368(25):2440-2. PubMed ID: 23782198
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J; Pike G; Keighley-Jones L; Nash MJ
    Am J Med; 2013 Aug; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.